Therefore, this may be caused by the fact that ELNV nanovesicles reverse the activation of CAFs and inhibit tumor fibrosis through the TGF-β/Smad signaling pathway, which further reduces TGF-β1 secretion in tumors. The gene discussed is TBX1; the disease is neoplasm.